MedPath

A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)

Not Applicable
Completed
Conditions
Posttraumatic Stress Disorder
Depression
Insomnia Disorder
Registration Number
NCT00984698
Lead Sponsor
University of Arizona
Brief Summary

The purpose of this study is to test the effectiveness of group psychotherapy designed specifically for male veterans and active-duty personnel with Post-traumatic Stress Disorder (PTSD), Major Depressive Disorder (MDD) and with disturbances in their sleep or daily routine.

Detailed Description

The purpose of this study is to test the effectiveness of a group psychotherapy designed specifically for male veterans and active-duty personnel with Post-traumatic Stress Disorder (PTSD), Major Depressive Disorder (MDD) and with disturbances in their sleep or daily routine. We will compare two group therapies, one of which has been examined in previous studies for veterans with PTSD. Both group therapies have been shown to reduce symptoms of anxiety and depression in some veterans. However, neither group therapy has been proven to be more effective than treatment as usual for PTSD.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
115
Inclusion Criteria
  • Veteran or active duty military personnel
  • Current posttraumatic stress disorder (PTSD), at least moderate severity
  • Criterion A exposure to trauma occurring after the age of 18
  • Major depressive disorder (MDD), at least moderate severity
  • Disturbances in sleep (primary insomnia, insomnia related to PTSD, or nightmare disorder) or daily routine
Exclusion Criteria
  • Current or past bipolar disorder
  • Current psychotic disorder
  • Substance abuse/dependence in last 30 days
  • Uncontrolled serious medical condition or neurological disorder
  • Currently working an overnight shift
  • Primary untreated sleep apnea, restless legs syndrome

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Depressionpost-treatment, at 12 weeks

Hamilton Rating Scale for Depression, 17 item The Hamilton Rating Scale for Depression is an interview assessment of depression symptom severity. Total score range is from 0 (no symptoms of depression) to 52 (maximum symptoms of depression).

Secondary Outcome Measures
NameTimeMethod
PTSDpost-treatment, at 12 weeks

Clinician-Administered PTSD Scale (CAPS), DSM-IV The CAPS is a 17-item interview assessment post-traumatic stress disorder (PTSD) symptom severity. Total score ranges from 0 (no PTSD symptoms) to 136 (maximum PTSD symptoms).

Trial Locations

Locations (2)

Southern Arizona VA Healthcare System (SAVAHCS)

🇺🇸

Tucson, Arizona, United States

University of Arizona

🇺🇸

Tucson, Arizona, United States

Southern Arizona VA Healthcare System (SAVAHCS)
🇺🇸Tucson, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.